Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCI001 Eye Drops in Healthy Male Subjects
NCT07640867Phase 1Completed
- Sponsor
- Rudacure
- Start
- Oct 2024
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of RCI001 in dry eye syndrome (DED) (10 arms), sponsored by Rudacure. Primary endpoints: Number of Participants With Adverse Events at Day 32 and Number of Participants With Clinically Significant Abnormalities in Safety Assessments at Day 32. Started Oct 2024; status: completed.
02
Drugs
RCI001
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT07640867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640867.